RecruitingNCT06746883

A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

A Single-arm, Open-label, Prospective, Observational Study to Assess the Safety of Sulbactam-durlobactam, Including the Risk of Hypersensitivity Reactions (Including Anaphylaxis) in Participants With Acinetobacter Baumannii-calcoaceticus Complex Infection

Sponsor

Innoviva Specialty Therapeutics

Enrollment

100 participants

Start Date

Apr 28, 2025

Study Type

OBSERVATIONAL

Conditions

Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)

Summary

The goal of this observational study is to evaluate the safety of sulbactam-durlobactam, as well as the risk of hypersensitivity reactions (including anaphylaxis) in participants with Acinetobacter baumannii-calcoaceticus complex infection. Participants will be followed for approximately 28 days in order to collect safety and reaction data.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Non-interventional for people with acinetobacter baumannii-calcoaceticus complex infection (abc). The study is currently recruiting participants at 10 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-interventional

Non-interventional

Locations(10)

University of Florida - Gainesville

Gainesville, Florida, United States

University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd

Kansas City, Kansas, United States

University of Kentucky College of Medicine

Lexington, Kentucky, United States

Ochsner Medical Center - New Orleans

New Orleans, Louisiana, United States

Ochsner LSU Health Science Center Shreveport

Shreveport, Louisiana, United States

Montefiore Medical Group Family Care Center

The Bronx, New York, United States

Summa Health System - Akron - 75 Arch Street

Akron, Ohio, United States

The Carl and Edyth Lindner Center for Research and Education at Christ Hospital

Cincinnati, Ohio, United States

University of Pittsburg School of Medicine

Pittsburgh, Pennsylvania, United States

Prisma Health - Infectious Diseases - Greenville

Greenville, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06746883

Related Trials

A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

NCT068012234 locations